Amicus Therapeutics (Nasdaq: FOLD) announced a broad strengthening of its biologics business strategy. The details of this important strategic repositioning ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE